June 3 (Reuters) -
Rapport Therapeutics:
* RAPPORT THERAPEUTICS INC SAYS CURRENTLY ESTIMATED IPO
PRICE WILL
BE BETWEEN $16.00 AND $18.00 PER SHARE - SEC FILING
* RAPPORT THERAPEUTICS INC SEES IPO OF UP TO 8 MILLION
SHARES OF
COMMON STOCK
Source text for Eikon: